COMPENDIUM OF PROMISING SOLUTIONS
"Interested in showcasing your innovation on our website? Apply here." Submit Your innovation
Innovation plays a vital role in improving health outcomes and strengthening healthcare systems. Identifying the right innovation that will be the right fit for the given problem statement becomes very critical and essential. Innovations must address any one of the following problem statements:
- Reduce cost of healthcare services.
- Improve last mile access
- Enhance quality
- Strengthen systems
- Promote equity
Categorization of the Health solutions
-
CareMother
AnandiMaa Year of launch: 2015CareMother is a pregnancy care platform for quality antenatal and postnatal care for underserved populations. It empowers frontline health workers with a diagnostic kit and an AI based app to identify and manage high risk pregnancies with remote monitoring by a doctor, thereby improving maternal and neonatal heath outcomes.
- Planning and intervention – digital health solution beyond reporting
- Inclusion of key stakeholders (ANM, Doctor, Hospital, Mother) for end to end utilization of data
- AI powered decision support for ANMs and referral
- Reporting as per local government guidelines that can be downloaded and used for decision making Data analytics dashboard for quick analysis
- Community Health Worker is trained by the CareMother team to use the portable kit and the mobile application.
- The health worker makes community visits regularly and registers a pregnant woman and records clinical history; conducts tests to measure vital clinical parameters as well as diagnostic tests using the CareMother kit.
- These tests evaluate haemoglobin, blood pressure, urine protein and sugar, weight, blood glucose, fetal heart rate, fundal height, pulse rate and oxygen saturation etc.
- The above data is entered into the CareMother app and the decision-support tool in the app allows the health worker to perform specific tests based on gestational age.
- The inbuilt iHRP algorithm detects the high risk and accordingly differentiates these women with color code.
- The list of pregnant women and their profile is also reflected in Doctor’s app which helps to provide necessary recommendation remotely.
- The app also notifies the health worker on nutrition advice and other health messages to be given to the mother, based on her stage and condition of pregnancy.
- CareMother has also launched a Mother’s App in three languages for use by women that have access to a smartphone. Through the app mothers will be able to access audio, video content related to care and nutrition, and alerts regarding their pregnancy and answers to common concerns during their critical phase of life. The app provides personalised information to the mother based on her gestational age.
- MIT Solve Winnerhttps://solve.mit.edu/challenges/healthy-cities/solutions/7902
- MHTF, Harvard on Personalised care:
- World Bank: Ideas 4 Action winner 2019 Winner,2019:
- CISCO Global Problem Solver Winner, 2018
- Harvard University’s “sense and sustainability blog” has re-published an article on CareMother- written by Ken Fullerton from G20: Young Global Changers
- E-mail
:
shantanu@caremother.in
- Phone : +91 9890400394
- Website : https://www.caremother.in
-
NeoBreathe
Easy to use infant resuscitator Year of launch: 2016NeoBreathe – NeoBreathe is an easy to use infant resuscitator that is empowering frontline health workers across the developing world to save the lives of newborns who fail to breathe at birth. It is the world’s first pedal operated multifunction resuscitator that reduces leakage and improves ventilation – making saving lives simple.
- Ventilation and Suction – Integrated into one system.
- Stable Grip and Seal – Effective seal deigned to prevent up to 50% of any leakage during procedure. Unit is safe, secure and prevents infection.
- Reusable Pressure Manometer – NeoBreathe has a built in reusable manometer for continuous pressure monitoring, which increases safety and confidence
- Regulated FiO2 Control – Inbuilt, low cost, multi point FiO2 regulation is available.
- Pressure Safety – Incorporated with patient safety measures. Pressure won’t exceed more than 40 cmH2O.
- PEEP Delivery and control
- Deployments across 20 states and 8 countries
- Helped over 5,000 babies
- ISO 13485:2016
- Indian patent granted, Design registered, Trademark accepted
- US Patent granted
- European patent granting soon
- Trade Mark – Application No. 4456503 (Status-Accepted and Advertised)
- BIRAC National Technology Award 2017 from Honorable President of India
- First prize in Innovation marketplace at Festival of Innovations 2017 at Rashtrapati Bhavan (India’s Presidential Palace)
- Supported by Every Woman Every Child Innovation Marketplace initiative of the United Nations
- Featured at UNGA, GES and many others
- Covered in several major Indian and International Media outlets
- Funded by Bill and Melinda Gates Foundation, US India Science and Technology Endowment Fund, Grand Challenges Canada, BIRAC, Villgro and WIN foundation.
- Follow-on personalized risk-specific communication through SMS/WhatsApp
- Africa (Countries: Mali, Kenya, Algeria, Congo, South Africa, Rwanda, Ivory Coast and others)
- India (States: Andhra Pradesh, Assam, Bihar, Chhattisgarh, Gujarat, Haryana, Jharkhand, Karnataka, Madhya Pradesh, Maharashtra, Nagaland, Odisha, Punjab, Rajasthan, Tamil Nadu, Telangana, Tripura, Uttar Pradesh, Uttarakhand, West Bengal
- E-mail
:
avijit@windmillh.com
- Phone : +91-9811802954
- Website : https://www.windmillh.com
-
Vaccineledger
Year of launch: 2016StaTwig’s signature product, Vaccineledger allows for end to end tracing of vaccines from manufacturers to the end customers, providing tracking ability to all the involved stakeholders through blockchain, recording and providing real-time tamperproof data to improve transparency.
- Built on blockchain platform
- Product based on UNICEF norms
- Studies real time data of vaccines in transit
- Forbes 30 under 30 India 2021
- UNICEF Innovation Fund Portfolio startup
- GAVI Infuse
- World Economic Forum Global Innovator
- NASDAQ Milestone Makers
- E-mail
:
keerthi@statwig.com
- Phone : 9160389999
- Website : https://statwig.com/
-
ANMOL
Auxiliary Nurse and Midwife Online Year of launch: 2015Auxiliary Nurse and Midwife Online (ANMOL) is an Android Tablet based Mother & Child Health application, used by ANMs for collection of the Mother & Children covering the below phases which includes
Eligible Couple | Pregnancy | ANC (Ante Natal Care) Delivery Outcome | PNC (Post Natal care) Vaccination
The Application allows ANMs to enter and update the service records of beneficiaries on real time basis.
- High Risk Pregnancies
- Non Compliance of Vaccinations
- Non awareness of Benefits and Safety of Institutional Deliveries
- Manual Data entry related latency of the Mother & Child Data
- Non availability tracking & monitoring system for planning and execution of Daily Activities of Frontline Health workers
- Non availability of Digital System, which track the health of Pregnant women in real time
- Eligible Couple: This module is used for new eligible couple registration and to track the family planning methods. Auto migration of eligible couple to pregnant women section when pregnancy recorded as positive.
- Pregnant Women: This module is used for the update tracking services of the beneficiary i.e. antenatal care services, delivery update, PNC period and Child PNC details
- Child Care: This module is used for the child registration and auto registration for child and linked to pregnant women records if delivery is reported through ANMOL and proper care of child for Immunization and growth.
- Dashboard of ANMs KPIs
- Village Health & Nutrition Day
- Counseling the Beneficiaries
- Work Plan generating, executing and tracking the daily work plan for ANMs
- Dynamic location master
- Google Play store Update
- Multilingual capability
- Integration with AADHAR
- AADHAR QR Code
- Provision for Offline / Streaming videos and audios for counselling section
- Integration with other applications & hardware like weighing machine etc
- IMR/MMR is significantly Reduced in the states where ANMOL is fully rolled out, due to growth in institutional deliveries and regular monitoring the Health of Pregnant women
- Productivity of ANMs is improved more than 100%, as they can meet & Counsel more number of beneficiaries by switching over to the Digital system from paper based manual version
- Improved Accuracy of the beneficiary data with ANMOL
- Facilitate in identification and tracking of High Risk Pregnancies and children with low birth weight.
- Job AID tools in ANMOL to ease ANMs day to day activity and helping in decision making
- Application allows ANM’s to enter and update the service records of beneficiaries on real time basis, which ensures prompt entry and updating of data
- Online Audio and Video counselling materials in Local language to help in Behavioral change and Awareness to Beneficiaries
- Timely SMS to Beneficiaries to inform about recent schemes of government and their respective due dates for Immunization and ANM services
- Assam
- Uttar Pradesh
- Madhya Pradesh
- Andhra Pradesh
- Telangana
- Odisha
- Himachal Pradesh
- Meghalaya
- Haryana
- Jammu & Kashmir
- Chhattisgarh
- Maharashtra
- Karnataka
- Chandigarh
- Goa
- Delhi
- Puducherry
- Punjab
- Manipur
- Jharkhand
- Arunachal Pradesh
- Mizoram
- Sikkim
- Tripura
- Nagaland
- Andaman & Nicobar
- E-mail
:
n.venkatesh@dhanushinfotech.com
- Phone : +91 40 49135000
- Website : https://www.dhanushinfotech.com
-
Khushi Baby
Year of launch: 2014The Khushi Baby system is a longitudinal digital solution which monitors and motivates reproductive and child health in last mile settings in India. Our solution consists of mobile applications for health workers, an offline digital medical record for beneficiaries, dashboard analytics for health officials, and automated dialect specific voice calls for community engagement.
- Maternal, Infant, and Under-5 Mortality
- Full Infant Immunization
- Antenatal Care Coverage
- High Risk Referral Care Completion
- Institutional Delivery
- Accountability of data and health service provision
- Access to informed care
- Awareness of health services and recommended health practices
- Actionable data analytics for health workers and officials
- Time-saving streamlined processes at the point of care
- 20,687 Pregnant Women Tracked
- 20,653 Infants Tracked
- 48,407 Antenatal Care Checkups
- 53,078 Infant Checkups
- 4,583 High Risk Mothers and Infants Identified and supported
- 886 Infant Lives Saved
- Certification from Rajasthan Government’s State Data Center
- Following Google Play Store’s Policy for deploying Mobile Applications
- A continuum of care which connects the village household, sub-centre and primary health center
- A mobile application for all healthcare providers, which replaces paper-based tracking, provides prioritized due lists and high risk lists, automates timely reporting of health outcomes and resource shortages, automates direct benefit transfers, and guides clinical decision-making
- Instant, offline sharing of digital medical records, via a Near Field Communication (NFC) health card, at the point of care
- GPS, NFC, and biometric accountability at all points of care. This confirms that 1) health camps were held and 2) the beneficiary met the provider
- Community engagement through dialect specific automated voice calls Sent as health camp reminders and health awareness messages
- In-field support to health workers through household follow up visits with high risk mothers and infants
- Actionable analytics and dashboard for health officials for timely decsion making
- Our extensive data sets enable us to build AI models to predict health worker diligence and filter high quality data to predict adverse maternal and infant health outcomes
- SPO Conference Emerging NGO Award 2017
- Aquent Design For Good Award
- NFC Forum’s Best Mobile App of 2017
- Digital India Awards 2017: Technology for Good in Healthcare
- Featured as part of the Digital India Heroes Series by Times Network
- Grand Challenges Canada Round 8 Stars in RMNCH Phase I Grantee
- Pierre Fabre Foundation Laureate of the Global South E-Health Observatory
- Johnson and Johnson Gen H Grand Prize winner
- Best Innovation at the Geneva Health Forum 2018
- Rajasthan, India
- E-mail
:
vikram@vitorhealth.com
E-mail 1: ruchit@khushibaby.org
E-mail 2: shahnawaz@khushibaby.org
- Phone : +91 9001469934
- Website : https://www.khushibaby.org
-
qXR
Year of launch: 2016qXR uses deep learning algorithms to read and triage chest X-rays in less than 1 minute and help detect 29 abnormalities including those that indicate presence of lung cancer, TB and COVID. Thereby reducing the chances of late diagnoses, under diagnoses and even potential misdiagnoses to deliver better patient care.
- Workflow optimization for reducing Radiologist workload with scan differentiation between normal and abnormals
- Pre-read assistance for clinicians and annotated image outputs and progression monitoring when multiple scans from the same patient are available.
- Reducing reporting turnaround with automated reports
- Screening in a community setting for Public health emergencies like Tuberculosis, Covid19
- Retrospective review of chest X-rays for audits and quality improvements
- 2016 – Nvidia Social Innovation Award
- 2017 – Netexplo award for innovative healthcare AI
- 2018 – CE certification for products
- 2018 – First AI company to be mentioned in the prestigious Lancet publication
- 2018 – NASSCOM AI Game Changer Award
- 2018 – Business Today Coolest Startup Award
- 2019- 2020 – Received 5 patents
- 2020 – Became the first Indian AI Company to receive FDA clearance
- India : Maharashtra, Rajasthan, Delhi, Bihar, Uttar Pradesh, Karnataka, and other states serviced by Teleradiology groups)
- Other countries: Canada, USA, Mexico, Brazil, Peru, UK, France, Germany, Italy, Zambia, Malawi, Kenya, South Africa, Oman, UAE, Pakistan, Myanmar, Cambodia, Vietnam, Thailand, Malaysia, Philippines, Indonesia, with moredeployments upcoming.
- E-mail
:
partner@qure.ai883
- Phone : --------------
- Website : https://www.qure.ai
-
Vitor Health Guard
Year of launch: 2018A portable health-screening kit, operated by a minimally skilled digital-health-agent, can be operated anywhere and anytime at the customer’s convenience. A health-screening takes about 10 minutes and an integrated health assessment in the form of an instant report is generated (in multiple local languages), containing simple yet actionable inputs.
- Human health status, in large parts of the world’s population, is moving towards chronic diseases being the largest killers – today more than 6 out of 10 people in the world die due to chronic diseases like diabetes, hypertension, cardio-vascular diseases, respiratory diseases, cancers etc.
- Health-seeking behavior is predominantly responsive and not preventive – people start responding only once something appears to occur (manifestation through pain, symptoms etc.). Chronic conditions are slow and silent and evolve inside the body without much indication – hence the individual has limited ability to identify risks. While household expenditure towards health has seen a steady rise, most of it is out-of-pocket and towards treating sickness. Today, and estimated more than 5% of India’s population falls into poverty annually due to one catastrophic health event in the family .
- The health-systems focus, especially in evolving and developing markets like India, is too focused on sickness treatment – hospitals, doctors and all stakeholders are focused on treating the “patient” once they come into the system. Very limited focus on early identification of “not-yet-but-soon-to-be-sick” populations.
- Accessibility: The Vitor solution can be deployed in the most commonly accessible touch points of our everyday life – our homes, our workplaces, our grocery story, our train commute, places of worship, thus making is very accessible and scalable
- Cost Effectiveness: The Vitor solutions enable providing customers health-risk assessments starting from price points of less than 1USD thus making it extremely affordable for large underserved populations.
- Power of technology and data sciences: The Vitor solution is built on top of certified, qualified and secure clinical, hardware, software and data technologies with ability to integrate seamlessly into current health-management-systems.
- Changing behaviors: The Vitor solution, on account of features that enable cultural nuances like language/dialect, trust, community-channels etc., ensures that there is positive and proactive change to health-seeking behaviors.
- Clinical grade medical devices that are FDA/CE certified
- Integrated risk-assessment coverage with indicators for obesity, cardio-vascular, respiratory, diabetes, anemia and vision related non-communicable-diseases.
- Seamless wireless data transfer from screening devices to servers to prevent data omissions & errors
- Tablet based technology solution for workflow automation and governance
- Portable and easily operable in any community setting
- Instant risk-assessment report with risk-summary supported in 8 Indian languages. Also sent instantly over SMS/WhatsApp to maintain personal-digital-health-record.
- Follow-on personalized risk-specific communication through SMS/WhatsApp
- Risk-specific products – Non-clinical and allied-health products which can offer quick solutions (Ex. Spectacles for vision issues)
- Follow-on Counseling – Health and lifestyle awareness and counseling and health-coach based support for condition management
- Tele-Consultation – Doctor consultation for risk assessment discussion, counseling and risk mitigation.
- Best Innovation Success Story in Startups/Innovators Category at the Lifesciences and Healthcare Innovation Forum 2018 by NASSCOM Centre of Excellence for AI/IoT
- 50 Startups to Take a Look at in 2019 by Insights Success
- E-mail
:
vikram@vitorhealth.com
- Phone : +91-6362909198
- Website : https://www.vitorhealth.com
- Independent care – diagnostics independent of extensive lab infrastructure
- Continuous Care – Diagnose correct and thereby treat correct on the first visit itself. Monitor treatment outcomes
- Cost effective Care – provide gold standard in testing at affordable costs
- Connected care – continuously identify disease hotspots, Globally, Identify new needs and provide solutions
- ISO certified
- CE marked
- Endorsed by WHO
- Rapid – raw sample to data under 60 minutes
- Simple – can be performed by a minimally trained person
- User Friendly – everything ready to use
- Portable – light weight – battery operated
- Reliable – extensively evaluated, WHO endorsed – based on the Taqman Chemistry
- Accurate – at par with state of the art
- Robust – designed for rugged conditions
- Date Transfer – wifi/gprs/bluetooth
- Affordable – Designed to meet the needs of Low and Middle-income countries
- Product of the year 2020- BIOSPECTRUM
- Across continents in more than 32 countries.
- E-mail
:
sumitmitra@molbodiagnostics.com
- Phone : +91 9822384883
- Website : https://www.molbiodiagnostics.com
- Usable by community health workers, primary health workers, nurses & technicians for use in primary care centers, public health centers, NGOs, Home healthcare and corporate health check-ups
- Digital breast exam that is easy to use with instant results at the point of care
- Accurately detects small breast lesions without the need for special infrastructure
- Quick breast exam within 5-7 minutes, painless and radiation-free
- Every scan is captured in the app and on the cloud with play-back and other features
- 400,000+ Women examined in 12 Countries
- Aided early detection of over 200 breast cancer cases
- Over 1M women to be examined soon with scans sold commercially
- iBreastExam Scanner: Hand-held, wireless, battery-powered scanner that collects tactile pressure data from the surface of the breasts non-invasively.
- iBreastExam Sensor Cartridge: Field-replaceable, hot-swappable Dynamic Co-Planar Capacitive (DCPC) Pressure Sensor that is pre-programmed with 500 scans.
- iBE Connect Mobile App: iBreastExam Scanner wirelessly communicates with the Mobile App to report the presence of breast lumps in real-time.
- Cloud Dashboard: LIVE and secure repository of all iBreastExam scans, accessible in the cloud.
- World Health Organization (WHO) has recognized iBreastExam as an Innovative Health Technology under the 2016-17 COMPENDIUM OF INNOVATIVE HEALTH TECHNOLOGIES FOR LOW-RESOURCE SETTING, Page 12 (Link: http://www.who.int/medical_devices/publications/compendium_2016_2017/en/) .
- $878,000 CURE Grant, Pennsylvania Department of Health, USA
- $300,000 University City Science Center, QED Program and Coulter Program at Drexel University
- $200,000 Global Health Innovation Grant, Pfizer Foundation
- $165,000 Grants 4 Impact, Bayer Cares Foudation
- $80,000 StartHealth, Unitus Seed Fund, India
- $50,000 Digital Health Accelerator, University City Science Center, USA
- $25,000 Helsinn – Lyfebulb Oncology Innovation Award Aspirin Innovation Award
- Bayer Cares Foundation Inclusive Innovation Award,
- Anjani Mashelkar Foundation Arab Health
- Innov8 Award, Dubai 2019
- Lexus Design Award, India 2018
- HITLabs Worldcup Award, NY 2016
- Accenture Healthcare Innovation Challenge Award, USA 2016
- IBM Smart Camp for HealthTech India, India 2016
- 2014 Marcum Innovator of the Year Award
- PACT Enterprise Awards LifeSciences Startup Company
- State Government of MaharashtraNitin Jairam Gadkari, Honorable Cabinet Minister for Road Transport & Highways & Cabinet Minister of Micro, Small and Medium Enterprises (India) – Non-profit NGO run by Mr. Gadkari has screened over 170,000 women in India with iBreastExam and the project is still ongoing. (we can provide video of his testimonial).
- State Government of Chhattisgarh
- Various Leading Cancer Care & Treatment Institutions
- A wing of Ministry of Defense, India (HVF Hospital) has been using iBreastExam since 2018 and supports using it for early detection of breast cancer. “We at HVF have been using iBreastExam device and found it extremely useful and convenient in providing routine breast health checkup to our staff and their families”, Dr. SK Das, Senior Specialist Surgery.
- Malabar Cancer Center, A Regional Cancer Center (RCC) site for the Government of India. MCC has undertaken the largest implementation study to date of 3,200 women in Kannur district to study the impact of iBreastExam in asymptomatic women population. Malabar Cancer Center is currently using iBreastExam in their breast health outreach program.
- E-mail
:
info@UELifeSciences.com
- Phone : +1 267 342 3303 (USA)
- Website : http://www.iBreastExam.com
- Measures hemoglobin in less than a minute
- Portable and easy to use
- Can measure hemoglobin from 0 – 24 g/dl
- Operate from 5 – 52 degree Celsius
- Connectivity – Bluetooth and USB
- Manufacturing License(CDSCO),
- ISO 13485:2016,
- European CE (Self Certified)
- Received US Patent in the year 2020
- Mitr35 award to the founder for invention of this product
- E-mail
:
a@wrig.in
- Phone : +91 99116 36088
- Website : http://www.aeonlife.io
-
Janitri
Year of launch: 2019Wearable and easy to use intrapartum fetal heart rate, uterine contraction and maternal heart rate monitoring device which also communicates with an intelligent intrapartum monitoring mobile application for automated WHO partograph and remote/central monitoring.
- Easy to use
- Portable/Wearable/Patient Mobility
- Fetal heart rate, uterine contraction and maternal heart rate monitoring
- Automated WHO partograph
- Remote/central monitoring
- Implemented in 100+ facilities,
- Monitored 30,000+ pregnant women during intrapartum period
- Winner of Falling Walls Labs 2016 India. Presented India in Falling walls conference 2016 Berlin, Germany
- The 10 Most Admired Medical Device Companies in 2017 by Insight Success
- Top 8 innovators of ASME iShow 2017 India
- Top 15 in Qualcomm Design in India Challenge 2018
- The 10 Most Prominent Healthcare Companies in 2018 by PrimeView
- Medicall 2019 Silver winner
- Meri award in “maternal and child healthcare” in 4th Commonwealth digital heatlh awards 2020
- Winner in India-Sweden healthcare Innovations Challenge
- Karnataka
- Rajasthan
- Meghalaya
- Arunachal Pradesh
- E-mail
:
arun@janitri.in
- Phone : +919952279155
- Website : https://janitri.in/
-
MiraCradle
Year of launch: 2015MiraCradle® Neonate Cooler is an affordable cooling device which uses the advanced savE® Phase Change Material (PCM) technology to induce therapeutic hypothermia among newborns suffering from birth asphyxia. It is easy to use, safe, light weight, portable and gives the precise temperature control of 33-34°C for a period of 72 hours with minimal manual supervision and no requirement of constant electricity supply.
- Affordable: Available at one tenth the cost of electrical devices.
- Efficient and clinically approved: Precise temperature control throughout the course of therapy (72 hours)
- CE certified
- Minimal maintenance: Developed for repeat use- no consumables Safe: Non-electric
- Impacting lives of 20,000+ babies in India every year
- Installed at over 300 hospitals pan India and over 500 worldwide Some of the hospitals include- CMC Vellore, JIPMER Puducherry, St John’s College Bangalore, SRMC Chennai, Apollo, Fortis, Max, AIIMS Jodhpur, AIIMS Bhubaneswar, Sir Gangaram Hospital, Jubilee Mission Medical College, Thrissur, etc.
- Conducted a capacity building program to reduce asphyxia deaths in the state of Rajasthan under Millennium Alliance (FICCI)
- Saving lives outside India. MiraCradle® was tested at at the Kenyatta National Hospital and was able to reduce severity of asphyxia from severe or moderate to mild or normal in some cases. Results were presented at the recent Kenya Paediatric Association Annual Conference and it was concluded that infants who suffer from birth asphyxia now have an effective affordable treatment option that can save lives and deter the onset of debilitating conditions like autism- http://www.villgrokenya.or.ke/node/169
- National Award (Technology Day Award), Government of India, May 2017
- MIT Innovators under 35 India Award- 2017
- Twice winner of CII Innovation Award- 2014 & 2017
- DST-Lockheed Martin India Innovation Growth Program- 2015;
- ASSOCHAM India Innovates Award- 2015;
- Included in WHO Compendium of Innovative Health Technologies for low resource settings- 2014;
- NRDC Meritorious Invention of the year- 2014
- Acknowledged by National Neonatology Forum (NNF) and published in their manual on therapeutic hypothermia (2017) to make aware and train thousands of neonatologists in the NNF network.
- Pan India
- We have distributor partners to supply and serve in countries outside India – Nepal, Sri Lanka, Malaysia, Indonesia, Thailand, South Africa, Kenya and other African and South East Asian countries
- The first trial was conducted on 41 babies. The mean (±SD) temperature during the cooling phase was 33.50 ± 0.39°C. Throughout the cooling phase, the target temperature range was maintained in 96.2% of the time. There was no temperature reading 32°C.Reference: Thomas et al. Phase changing material: an alternative method for cooling babies with hypoxic ischaemic encephalopathy. Neonatology. 2015;107(4):266-70. Epub 2015 Feb. PMID:25720449.
- The second trial was conducted on 103 babies and at 10 different hospitals. The median (IQR) of time taken to reach target temperature was 90 (45, 120) minutes. The mean (SD) deviation of temperature during cooling phase was 33.5 (0.39°C). Temperature readings were outside the target range in 10.8% (5.1% of the readings were 33°C and 5.7% were >34°C). Mean (SD) of rewarming was 0.28 (0.13)°C per hour.Reference: Thomas et al. Phase Changing Material for Therapeutic Hypothermia in Neonates with Hypoxic Ischemic Encephalopathy A Multi-centric Study. Indian Pediatrics. 2017. Epub 2017 Dec. PMID:29242417.
- Another independent study conducted over 50 babies concluded in supporting the beneficial effect of the therapy by the device in newborns with HIE.Reference: Saraswat et al. Therapeutic hypothermia in asphyxiated neonates, using phase change material (Mira Cradle): experience from neonatal intensive care unit of tertiary care centre South India. Indian Pediatrics. 2019. International Journal of Paediatric Research. Online ISSN: 2349-3267
- Randomized Controlled Trial.This study confirmed that TH induced by PCM reduced brain injury detected on MRI in infants with moderate HIE in a neonatal intensive care unit in India.Reference: Aker et al. Therapeutic hypothermia for neonatal hypoxic-ischaemic encephalopathy in India (THIN study): a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2019; 0:F1–F7. doi:10.1136/fetalneonatal-2019-31731. Published by BMJ
- E-mail
:
Udit.mangal@pluss.co.in
- Phone : 9871304861/ 9763081045
- Website : https://www.miracradle.com
-
MedGames
Simulated learning platform Year of launch: 2019Bodhi Health’s award-winning game-based, simulated learning platform makes learning fun, motivating and adaptive for the clinical workforce. Every learner is presented with a set of real-life, simulated patient cases in various clinical areas. The game platform is designed to help clinicians sharpen their critical thinking skills and practice evidence-based care in a virtual and safe environment.
- Heavy dependence on nurses to provide basic healthcare services in developing countries in the absence of doctors
- Skill gaps that exist among pre-service & in-service nurses
- Medical errors often proving fatal to patients due to insufficient practical exposure/training
- High maternal and child mortality rates by unskilled health workers while handling complicated pregnancy cases
- Lack of avenues to high-quality continuing education platforms for nurses to keep up-to-date with latest guidelines and protocols
- Simulates real-life clinical cases with focus on application of knowledge & decision-making skills
- Practice evidence-based care in a virtual-safe environment
- A leader board helps nurses track their progress and engage in healthy competition with their peers
- AI algorithm generates personalised learning path for every user
- The platform is easily customizable and can be extended to simulate cases in other languages & areas such as infection control, medication administration, assessment skills, care prioritization, wound/dressing, ECG interpretation etc.
- ASMAN game app has been successfully rolled out in 81 facilities across 8 districts in Indian states of Madhya Pradesh and Rajasthan.
- Total1046 healthcare providers have been trained. 698 in Madhya Pradesh and 348 in Rajasthan
- 913 trained service providers
- India – Delhi, Rajasthan, Madhya Pradesh, Hyderabad, Maharashtra, Tamil Nadu
- Indonesia
- Myanmar
- E-mail
:
Shrutika@bodhihealthedu.org
- Phone : +91-9999590442
- Website : https://bodhihealthedu.org/
-
Doxper
Year of launch: 2016InformDS Technologies is India’s leading healthcare digitisation solution, and the largest source of longitudinal real world data in the outpatient setting. Its proprietary, AI assisted digital pen and paper solution allows doctors to instantly digitise their case sheets without any change in behaviour or workflow.
- Continue writing: no change in behaviour or workflow
- Works offline and in any care setting
- Seamlessly capture data longitudinally and across multiple users
- Proprietary handwriting recognition algorithms speed up data transcription and medical coding
- 48 corporate hospitals as customers
- 4000 doctors across specialties as users
- Digitized records of 4 million unique patients
- Equipment Type Approval Certificate, Ministry of Communication and Information Technology, Government of India
- CE Certification, Radio Equipment Directive, European Union
- Equipment Authorization, Federal Communications Commission, United States
- Write with Doxper digital pen on regular, coded paper.
- Handwritten strokes sync with Doxper app in real-time via Bluetooth. Option for offline storage.
- Data is processed in the cloud with AI assisted handwriting recognition
- Integrates with any EMR with intuitive APIs. Coded case sheets can be printed on-site in hospitals.
- MIT-Solve Challenge Winner (US) [2017]
- Nasscom Emerge 50 Winner (India) [2018]
- Asia Paciifc HIMSS-Elsevier Digital Healthcare Award (Australia) [2018] Our customer Nanavati Hospital had submitted a case study of Doxper and was shortlisted as a top 4 finalist.
- Arogya Manthan – 1st year anniversary of PM-JAY, Ayushman Bharat (India) Doxper was one of 5 startups recommended by NatHealth and selected to showcase its technology to key decision makers and state officials including the honourable health minister at Vigyan Bhavan, Delhi [2019]
- Cahotech 2020 – Virtual Pitchfest Awardee [2020]
- India, present in over 50 cities
- Ivory Coast
- Nigeria
- Indonesia
- Morocco
- Bangladesh
- South Korea
- E-mail
:
parag@informds.com
- Phone : 8882599599
- Website : https://www.doxper.com
CareMother - AnandiMaa Year of launch: 2015
Core healthcare issue/need being addressed
Maternal/ Pregnancy care
Key value add
Impact of the solution
The solution has benefitted over 40,000 pregnant women across India and trained over 1000 health workers
Regulatory/Quality Certifications
CE certified
Video links
Detailed description of the solution and its components
CareMother is a complete solution for pregnancy care and has been designed with the specific purpose of providing quality antenatal and postnatal services to the underserved and marginalised population of our country. It consists of a portable kit used by a health worker for home-based or centre-based point-of-care antenatal tests, and a smartphone application with a ‘decision-support tool (DST)’ for detecting high-risk pregnancies, delivering specific counselling messages to mothers and their referral to doctors and/or transfer of real-time results for prompt clinical decisions. The tests include height, weight, pulse, blood pressure, haemoglobin, urine protein and sugar, blood sugar, fundal height and fetal heart rate. Trained frontline workers can deliver personalized pregnancy care through the DST that fetches data from doorstep antenatal tests and classifies risk and further course of action.
How it Works
Awards and recognition
Geographical presence
CareMother is currently being implemented in 14 locations in India, across tribal, rural and urban areas, with strategic partners including four government entities. We are present in Maharashtra (including Mumbai, Nandurbar, Aurangabad, Palghar districts), Nagaland, Gujarat, Himachal Pradesh, Madhya Pradesh Rajasthan and Karnataka. International – Nigeria, soon to start in Bangladesh and Afghanistan
Scientific evidence
https://fetosense.com/assets/publictions/I4A.pdf#toolbar=0&navpanes=0&scrollbar=0
https://fetosense.com/assets/publictions/PCA.pdf#toolbar=0&navpanes=0&scrollbar=0
https://cisco.innovationchallenge.com/cisco-global-problem-solver-challenge-2019/winners
OECD DEVELOPMENT COOPERATION REPORT: OECD (2018), “Bringing affordable and accessible maternal healthcare to the poorest districts of India”, in Case Studies on Leaving No One Behind: A companion volume to the Development Co-operation Report 2018, OECD Publishing, Paris.
About the Organization
Name of the organization
CareNX Innovations Private Limited (CareMother)
Office Addres
201, Greenscape Technocity, MIDC Industrial Area, Mahape, Navi Mumbai 410700
Shantanu Pathak, Co-Founder and CEO
NeoBreathe - Easy to use infant resuscitator Year of launch: 2016
Core healthcare issue/need being addressed
Reducing infant mortality is a key global priority. Newborn deaths account for 80% of infant mortality. Of these 24% (third largest cause) are caused by birth asphyxia, which is fully treatable by definition. This condition also inflicts a similar number of survivors with life-long mental and physical disability. Nearly all of these tragedies occur in the developing. NeoBreathe aims to address these grim numbers and ensure a brighter chance for a healthy life for newborns irrespective of the place of birth.
Key value add
Impact of the solution
Regulatory/Quality Certifications
Video links
A video telecast on DD National in May 2014 (“Hunarbaaz” Episode 9, uploaded to YouTube on 13th May 2014) 26:47 to 29:49 (with multiple references to NeoBreathe, last one being at 29:48)
https://youtu.be/LnJPVjuuev8?t=1607
Video on NeoBreathe commissioned by US India Science and Technology Endowment Fund, upload date 8 May 2017
Press coverage
A yourstory.com article about us dated 28th May 2013
https://yourstory.com/2013/05/5-out-of-100-babies-wont-breathe-at-birth-startup-windmill-alleviates-the-situation-2
Article in outlook Business magazine, published on 20 Sep 2016
https://www.outlookbusiness.com/enterprise/feature/heart-set-on-innovation-3036
Tweet dated 6th Aug 2017 by Dr. Harsh Vardhan, then Honorable Union Minister for Science and Tech, mentioning NeoBreathe
https://twitter.com/drharshvardhan/status/894214181188059138
Economic Times article dated 28 Dec 2018 mentioning NeoBreathe
https://economictimes.indiatimes.com/small-biz/startups/how-medical-devices-startups-have-reached-niche-but-potentially-lucrative-markets/articleshow/52680711.cms
Special program made by Indian Science – telecast on DD National in 2019, uploaded on website March 2020 (10:24 to 14:33)
https://www.indiascience.in/videos/devices-for-mother-and-child-healthcare-e
Detailed description of the solution and its components
NeoBreathe is a foot operated resuscitator – It frees one hand of the operator from the task of pressing a bag. This freed hand when used to hold the mask with both hands has been proven to reduce face-mask leakage by 50% and improve ventilation by 15-20%. The freed hand also allows more effective multi-tasking.
When skilled manpower is short – this can make all the difference. For instance, it allows a single operator to perform full CPR – something that needs two skilled persons otherwise. the single operator can also auscultate, position the airway and do a lot more – all alone.
NeoBreathe also includes foot powered suction – essential for clearing the airway prior to ventilation. Being manual and integrated ensures that reliable is always available during resuscitation. Other salient features include enhanced pressure safety, pressure monitoring, Positive End Expiratory Pressure and the ability to deliver regulated amounts of oxygen – as opposed to blindly delivering 100% oxygen which can be toxic.
Awards and recognition
Geographical presence
Scientific evidence
Peer reviewed publications in reputed BMJ Innovations Journal dated 3rd Jan 20
https://innovations.bmj.com/content/6/2/48.full
About the Organization
Name of the organization
Windmill Health Technologies Private Limited
Office Addres
53 First Floor, Shahpur Jat, New Delhi – 110049, IND
Dr. Avijit Bansal, Founder & CEO
Vaccineledger Year of launch: 2016
Core healthcare issue/need being addressed
Vaccine supply chain optimization and real time insights- Our product mainly records real time data of vaccines in transit including location, humidity, temperature and other constraints. This ensures that vaccines reach the end beneficiary in the right condition, preventing any wastage of vaccines. The QR codes present on the vaccines also ensure at each point if there are any counterfeit products introduced in the supply chain.
Key value add
Impact of the solution
Currently our solution is being used to track the Covid vaccine, which needs to reach 1.3 billion population in India, with backing from UNICEF, GAVI and WEF.
Press coverage
Detailed description of the solution and its components
Vaccineledger allows for end to end tracing of vaccines from manufacturers to the end customers, providing tracking ability to all the involved stakeholders through blockchain, recording and providing real-time tamperproof data to improve transparency. Every product is assigned a unique id and alphanumeric code that is globally recognized, allowing the product’s lifecycle to be traced efficiently from production, through to distribution and dispensation to patients at the drugstore or hospital. It tracks constraints such as location, humidity, temperature.
Awards and recognition
Geographical presence
India, US, Netherlands
About the Organization
Name of the organization
StaTwig
Office Addres
Thub Hyderabad
Keerthi Reddy
ANMOL - Auxiliary Nurse and Midwife Online Year of launch: 2015
Core healthcare issue/need being addressed
The major challenges addressed by the ANMOL Solutions are
Key value add
Data reporting Features
ANMOL is enabled to collect all information related to RCH Program the key modules for data reporting features are as follows,
A Job Aid Features
In addition to the above, ANMOL acts as job aid tool to the ANMs by providing them with readily available information such as due list, dashboard and guidance based on data entry. Videos/audios on subject like high-risk pregnancy, immunization, family planning etc. are also available in the application for use by ANM. The key modules are as follows
ANMOL- Offline Feature
Anmol works in both online and offline mode
ANMOL – Custom features
ANMOL application has some very distinctive technical features such as
Impact of the solution
Video links
Detailed description of the solution and its components
ANMOL application facilitates allows ANMs for collection and maintenance of information on aspects like family planning, maternal health, child health and immunization. ANMOL also acts as a job aid to the ANMs by providing them with readily available services such as work plan, due list, dashboard and guidance based on data entered etc. ANMOL ensures more prompt entry and Update of data as well as improve the data quality since the data will be entered “at source” (by providers of health services themselves).
Key value add of the solution
Awards and recognition
SKOCH AWARD – ANM Online Implementation, National Health Mission, Government of Haryana
Geographical presence
ANMOL is being rolled out across the country, With below States having already initiated adoption of ANMOL. Where Dhanush is providing Rollout Implementation, Training and Helpdesk Support for this Nationwide Mission:
About the Organization
Name of the organization
Dhanush InfoTech Private Limited
Office Addres
#1-8-448, Lakshmi Building, 5th & 6th Floors, Begumpet, Hyderabad, Telangana, India, PIN 500 003.
Venkatesh Natarajan, Designation: Director
Khushi Baby Year of launch: 2014
Longitudinal Reproductive, Maternal, Neonatal and Child Health (RMNCH) Platform pid Screening & Health Risk Assessment Solution
Core healthcare issue/need being addressed
Key value add
Impact of the solution
Regulatory/Quality Certifications
Detailed description of the solution and its components
Over 5 years, we have created a user-friendly and culturally sensitive digital platform to track reproductive, maternal, neonatal and child health care. Our platform is tailored for last-mile settings with poor connectivity and covers an integrated digital health census, family planning, antenatal care, labor monitoring, immunization and child health.
RMNCH Platform Components
Awards and recognition
Other resources
Latest Annual Report (2019-2020)
https://improvingphc.org/sites/default/files/Rajasthan_telehealth.pdf
Geographical presence
Scientific evidence
International Initiative for Impact evaluation report
https://www.sciencedirect.com/science/article/pii/S0264410X17315827?via%3Dihub
https://arxiv.org/pdf/2011.02962v4.pdf
Other resources
Latest Annual Report (2019-2020)
https://improvingphc.org/sites/default/files/Rajasthan_telehealth.pdf
About the Organization
Name of the organization
Khushi Baby
Office Addres
123, Kharol colony, Gali No.5, Fatehpura, Udaipur, Rajasthan-313001, India
01: Ruchit Nagar, CEO
Name and designation of the contact person 1
02: Mohammed Shahnawaz, COO
qXR Year of launch: 2016
Core healthcare issue/need being addressed
Across the world, the doctor-patient ratio is low, and this is even more true in the case of specialized practitioners such as radiologists. Radiologist expertise is scarce, expensive and unequally distributed. This means that not all patients receive an accurate, timely diagnosis. This is the gap Qure.ai is addressing: making quality healthcare accessible and affordable—even in remote locations, and even for some of the world’s most vulnerable populations using advanced AI technology that automates radiology imageinterpretation. In case red flags appear on the X-ray, the patient can be referred for immediate physician consult.
Key value add
Impact of the solution
XR has made it possible to provide easy access to diagnostics to the most vulnerable sections of the society. In some cases, we have seen through the use of our technology as a preliminary screen – an overall 50% increase in microbiologically confirmed TB cases as opposed cases opposed to clinical diagnosis – which is often diagnosed based symptom presentation. qXR can reduce the reporting workload of physicians by 40% qXR has to date been validated in multiple geographies, with 9 independent studies published. It’s currently live in over 20 countries and has processed almost 750,000 scans to date.
Regulatory/Quality Certifications
CE certified and hosted on GDPR/ HIPAA compliant servers for processing of scans.
Video links
Covid-19: https://www.youtube.com/watch?v=8_yIT0jUnms
For the Radiology workflow: https://www.youtube.com/watch?v=El_g67JbdF4
For TB screening: https://www.youtube.com/watch?v=keDCOLsn1hw
Detailed description of the solution and its components
Qure.ai’s qXR tool delivers automated chest x-ray interpretation. The technology accurately detects abnormal chest x-ray findings and can be used to distinguish between normal and abnormal x-ray findings, for pre-read assistance, or as a radiology audit tool. qXR screens for lung nodules, Tuberculosis (TB), COPD, lung malignancies in high-risk populations, and certain cardiac disorders, identifying and localizing as many as 29 common abnormalities.
Because of its versatility and ability to quickly integrate into any client users’ existing software design or workflow, qXR technology is applicable for virtually any health care setting. Customers include major metropolitan hospitals, managed care medical centers, and government departments/ministries of health.
Since Qure.ai’s deep learning capabilities dramatically improve the time-to-diagnosis and aid in prioritizing cases, the technology is also well-suited to support small radiology departments in community hospitals, and also to assist teleradiology entities that typically manage thousands of x-ray images and scans (requiring prompt turnaround).
Awards and recognition
Geographical presence
Qure.ai is present in 30 countries, with more than 150 sites, touching close to a 1 million lives. In India, qXR is deployed in close to 14 states, through more than 45 sites.
Scientific evidence
Shadi Ebrahimian, Fatemeh Homayounieh, Marcio A. B. C. Rockenbach, Preetham Putha, Tarun Raj, Ittai Dayan, Bernardo C. Bizzo, Varun Buch, Dufan Wu, Kyungsang Kim, Quanzheng Li, Subba R. Digumarthy & Mannudeep K. Kalra. Artificial intelligence matches subjective severity assessment of pneumonia for prediction of patient outcome and need for mechanical ventilation: a cohort study.
https://www.nature.com/articles/s41598-020-79470-0
Faiz Ahmad Khan, Arman Majidulla, Gamuchirai Tavaziva, Ahsana Nazish, Syed Kumail Abidi, Andrea Benedetti, Dick Menzies, James C Johnston, Aamir Javed Khan, Saima Saeed. Chest xray analysis with deep learning-based software as a triage test for pulmonary tuberculosis: a prospective study of diagnostic accuracy for culture-confirmed disease. The Lancet Digital Health,Volume 2, Issue 11, e573 – e581.
https://www.thelancet.com/journals/landig/article/PIIS2589-7500(20)30221-1/fulltext
Mushtaq, J., Pennella, R., Lavalle, S. et al. Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients. Eur Radiol (2020).
https://doi.org/10.1007/s00330-020-07269-8
Qin ZZ, Ahmed S, Sarker M S, Paul K, Adel A S S, Naheyan T, Banu S, Creswell J. Can artificial intelligence (AI) be used to accurately detect tuberculosis (TB) from chest x-ray? A multiplatform evaluation of five AI products used for TB screening in a high TB-burden setting.
https://arxiv.org/abs/2006.05509
Engle E, Gabrielian A, Long A, Hurt DE, Rosenthal A (2020) Performance of Qure.ai automatic classifiers against a large annotated database of patients with diverse forms of tuberculosis. PLOS ONE 15(1): e0224445.
https://doi.org/10.1371/journal.pone.0224445
Nash M, Kadavigere R, Andrade J, Sukumar CA, Chawla K, Shenoy VP, et al. Deep learning, computer-aided radiography reading for tuberculosis: a diagnostic accuracy study from a tertiary hospital in India. Sci Rep. 2020 Dec 1;10(1):1–10.
https://doi.org/10.1038/s41598-019-56589-3
Qin ZZ, Sander MS, Rai B, Titahong CN, Sudrungrot S, Laah SN, et al. Using artificial intelligence to read chest radiographs for tuberculosis detection: A multi-site evaluation of the diagnostic accuracy of three deep learning systems. Sci Rep. 2019 Dec 1;9(1):1–10.
https://doi.org/10.1038/s41598-019-51503-3
Putha P, Tadepalli M, Reddy B, Raj T, Chiramal JA, Govil S, et al. Can Artificial Intelligence Reliably Report Chest X-Rays?: Radiologist Validation of an Algorithm trained on 2.3 Million XRays. 2018 Jul 19 [cited 2020 Mar 30]; Available from:
http://arxiv.org/abs/1807.07455
Singh R, Kalra MK, Nitiwarangkul C, Patti JA, Homayounieh F, Padole A, et al. Deep learning in chest radiography: Detection of findings and presence of change. Eapen GA, editor. PLoS One [Internet]. 2018 Oct 4 [cited 2020 Mar 30];13(10):e0204155. Available from:
https://journals.plos.org/plosone/article/comments?id=10.1371/journal.pone.0204155
About the Organization
Name of the organization
Qure.ai
Office Addres
Qure.ai Technologies Pvt. Ltd, Level 7, Commerz II, International Business Park Oberoi Garden City, Western Express Hwy,Goregaon E, Mumbai, Maharashtra 400063
Ammar Jagirdar, Head, Products
Vitor Health Guard Year of launch: 2018
Rapid Screening & Health Risk Assessment Solution
Core healthcare issue/need being addressed
There are 3 key indicators, which are significant barriers to the healthcare system today:
The focus of Vitor Health’s solution is to bring in the ability, in a very simple, convenient and cost-effective manner, the ability to identify health risks very early for large populations and through a technology-lead approach, provide opportunities to minimize or mitigate the adverse effects of those health risks.
Key value add
Impact of the solution
Since June 2018, we have impacted 74,150 users who have undergone health screening using the Vitor Health Solution across more than 250 locations in India.
Detailed description of the solution and its components
The Truelab Real Time micro PCR platform – decentralizes MDx testing for Infectious Diseases from the central Laboratory to the Patient bedside (Near Patient Care – Point Of Care). The platform, is a start to finish platform, endorsed by the WHO
Health Assessment – This part provides the customer the ability to measure their health status in a simple, easy and quick manner. The key feature is a health-screening kit, weighing a little over 4Kgs, enabling the couduct of a health-screening anywhere and anytime. The overall health-screening activity takes less than 15-minutes per person thereby greatly reducing the opportunity-cost friction associated with going to a healthcare setting to get a checkup done. The key features of the health-assessment solution are:
Health Appreciation – This part of the solution makes it easy and relevant for the customer to understand health-risk reporting and brings further engagement towards once own health. This combined with hyper-personalized follow-on communication after the screening nudges the customers towards proactive health seeking action. The key features of the health-appreciation solution include:
Health Action – This part of the solution provides specific risk-mitigation or risk-management options for customers to enagage with in order to prevent, eliminate or minimize the chronic conditions. Some of the current available health action services are:
Awards and recognition
Geographical presence
Current deployments have been only in India, in the following states: Karnataka, Kerala, Tamil Nadu, Andhra Pradesh, Telangana, Maharashtra, Madhya Pradesh, Gujarat, Rajasthan, Haryana, Uttar Pradesh, Himachal Pradesh, Chhattisgarh, West Bengal, Orissa, Assam and Delhi-NCR.
About the Organization
Name of the organization
Vitor Healthsciences Private Limited (Vitor Health)
Office Addres
B904 Magnolia Block, Brigade Millennium, J.P.Nagar 7th Phase, Bangalore 560078
Vikram Rai, Co-Founder & Director
TrueNat Year of launch: 2013
Core healthcare issue/need being addressed
Understanding the importance and need for SIMPLE, RAPID , RELIABLE, ACCESSIBLE and AFFORDABLE Molecular Diagnostics tools for EARLY & ACCURATE diagnosis of disease, especially devastating infectious diseases, MOLBIO invested into more than a decade of research, in conceptualizing, designing , developing, manufacturing and commercializing the patented Truelab Real Time micro PCR Platform and the Truenat disease specific micro PCR chips.
Key value add
Impact of the solution
Between April 2020 to December 2020, over 3,000 units were installed in Pan India during COVID pandemic and millions of the Indian population from Leh Ladakh in North to Arunachal Pradesh in the East of India and in the world were tested with the Truenat COVID assays.
The National TB Elimination Programme benefited too with greater case detection at the remotest corners of the country. Early and correct diagnosis paved way for early and appropriate treatment and follow up.
Regulatory/Quality Certifications
Video links
Detailed description of the solution and its components
The Truelab Real Time micro PCR platform – decentralizes MDx testing for Infectious Diseases from the central Laboratory to the Patient bedside (Near Patient Care – Point Of Care). The platform, is a start to finish platform, endorsed by the WHO
The salient features of the platform are:
Awards and recognition
Geographical presence
About the Organization
Name of the organization
MOLBIO DIAGNOSTICS (P) LIMITED
Office Addres
Plot No. L - 46, Phase IID,Verna Industrial Estate ,Verna - Goa - India - 403722
Sumit Mitra, President - Global S&M Skype : sumitm67
iBreastExam Year of launch: 2016
Core healthcare issue/need being addressed
Worldwide, breast cancer is the most common cancer amongst women. While highly treatable, for women in low- and middle-income (LMIC) countries, breast cancer is most often diagnosed late, with poor prognosis. In these parts, there are limited options to enable access to early detection of breast cancer at scale. Clinical Breast Examination is manual and subjective, has limited accuracy in the field and requires extensive training. Mammographic screening has a number of other limitations for younger women with dense breasts, involves painful compression of the breasts as well as use of ionizing radiation. Availability of expert radiologists to interpret x-ray based mammograms is also challenging.
There is a need for accessible and affordable breast cancer early detection that is easy, quick, accurate, painless and radiation-free.
Key value add
Impact of the solution
Regulatory/Quality Certifications
| US FDA | Myanmar FDA |
| CE Certificate | Egypt Ministry of Health |
| COFEPRIS | ISO 13485 |
| Malaysia FDA | ISO 9001 |
| Thailand FDA | WHO GMP |
Video links
TED Talk Video Link
https://www.ted.com/talks/mihir_shah_a_new_technique_to_save_women_s_lives_from_breast_cancer)
BBC World News Video Link
https://www.ted.com/talks/mihir_shah_a_new_technique_to_save_women_s_lives_from_breast_cancer)Press coverage
Press coverage
The New York Times Article Link
https://www.nytimes.com/2018/08/28/opinion/detect-breast-cancer-developing-countries-asia.html)
Vogue Article Link
https://www.vogue.com/article/early-breast-cancer-detection-technology)
Detailed description of the solution and its components
Awards and recognition
Other resources
iBreastExam Brochure Link
https://uploads.strikinglycdn.com/files/40f66aa0-7b40-46d9-8bd8-764c64b96281/iBE%20GEN%20II%20Brochure%20-%20Pink.pdf)
Clinical Studies Link
https://www.ibreastexam.com/doctors)
Geographical presence
Following regulatory approvals, iBreastExam is currently being used commercially in these countries: India, Malaysia, Thailand, Indonesia, Myanmar, Nepal, Oman, Botswana, Mexico, Egypt
In India, below agencies have already implemented iBreastExam and are in process of implementing iBreastExam in several breast health and outreach programs. These programs have already screened over 250,000 women in India.
In Malaysia, the State Government of Johor is planning to implement a breast health program to screen 40,000 women following successful evaluation conducted in collaboration with Malaysia’s largest hospital network, KPJ Hospitals.
In Mexico, The Mexican Navy, States of Mexico, Oaxaca, Campeche, Puebla and Tabasco as well as other agencies and groups have screened over 25,000 women.
About the Organization
Name of the organization
UE LifeSciences
Office Addres
3401 Market St, Suite 200, Philadelphia PA 19104 (USA) 302 – Trimabh Niwas, Relcon House, MG Road, Vile Parle (E), Mumbai – 400057 (India) B1-1-3A, Solaris Dutamas, 1 Jalan Dutamas, Kuala Lumpur – 50480 (Malaysia)
Mihir Shah - Founder
TrueHb Monitoring Kit Year of launch: 2009
Core healthcare issue/need being addressed
Anemia , Chronic Kidney Disease, Menorrhagia, Thalassemia.
Key value add
Impact of the solution
The only Indian Manufacturer of Hemoglobin Meter which has covered almost 60% of Indian Market. We have installed 70k devices in 4 years.
Regulatory/Quality Certifications
Detailed description of the solution and its components
TrueHb Hemoglobin Monitoring Kit measures total hemoglobin in the human blood within a minute. We have installed 70,000 devices in India, and working with different state governments, healthcare homes, blood banks, clinics, pathology labs, Healthcare ATMs, and others. The device works on the Reflectance photometry principle with a Lithium-Ion battery having a weight of 60 grams. The operating temperature of the device is 5 c to 52 c and the range of measurement is 0-24g/dl, the device also gives the facility of Bluetooth connectivity where the data can be recorded and shared on a daily basis for a routine checkup on laptop, phone or TAB.
Awards and recognition
Geographical presence
Pan India
About the Organization
Name of the organization
Wrig Nanosystems Private Limited
Office Addres
Plot 170, 2nd Floor, Patparganj Industrial Area, Patparganj, Delhi-110092
Mr. Ambar Srivastava- Managing Director
Janitri Year of launch: 2019
Core healthcare issue/need being addressed
Every year, an estimated 1.02 million intrapartum stillbirths, 904000 intrapartum neonatal deaths & 250000 maternal deaths occur globally. More than 99% of those deaths occur in developing countries like India and Africa. In India, more than 80% deliveries conducted in low resource healthcare settings which lack of killed healthcare workers and medical devices. During intrapartum period, fetal heart rate and uterine contraction monitoring is really important to know the status of the mother and fetus, but monitored inaccurately and ignored more than 85% of the time. This leads to mortality/morbidity in case of any anomaly.
Existing device cardiotocography is high cost (>3000 USD), non-portable (5 Kg) and required skilled healthcare worker for continuous monitoring of FHR & uterine contraction displays both the parameters in a graphical format. In current practice, gynaecologist analyzes the pattern of fetal heart rate & uterine contraction on printed CTG graph to recognize the fetus distress. Based on that, they take early decision to prevent any mortality or morbidity.
WHO Partograph is designed to monitor & make timely interventions to prevent complications during the intrapartum period. More than 90% of the midwives fill the partograph after delivery, that too for the data recording formality.
Key value add
Impact of the solution
Regulatory/Quality Certifications
Received CDSCO NOC, Pre-compliance testing
Detailed description of the solution and its components
KEYAR is an easy to use patch based fetal heart rate, uterine contraction and maternal heart rate monitoring device for intrapartum period. The patch gets connected to the handheld unit. The handheld unit has an inbuilt processor, circuits, battery and small display to show case the required readings and graphs. It can work as an independent wearable monitoring device. KEYAR uses the electrical signal based technology to pick up the fetal ECG, maternal ECG and uterine EMG and further calculate fetal heart rate, uterine contraction and maternal heart rate.
KEYAR can also communicates with DAKSH which is an intrapartum monitoring mobile application for the intelligent alerts, automated WHO partograph generation and remote monitoring. DAKSH has 3 components. One is for the staff nurses/midwives which can be used inside the labor ward. Second one is for the doctor/OBGYNs which can be used to see data anywhere live. Third one is the dashboard/centralized monitor to see the overall data.
KEYAR can also communicates with DAKSH which is an intrapartum monitoring mobile application for the intelligent alerts, automated WHO partograph generation and remote monitoring. DAKSH has 3 components. One is for the staff nurses/midwives which can be used inside the labor ward. Second one is for the doctor/OBGYNs which can be used to see data anywhere live. Third one is the dashboard/centralized monitor to see the overall data.
Awards and recognition
Geographical presence
Scientific evidence
About the Organization
Name of the organization
Janitri Innovations Private Limited
Office Addres
3rd Floor, 338, 27th Main Road, Sector 3, HSR Layout, Bangalore, 560102
Arun Agarwal (Founder & CEO),
MiraCradle Year of launch: 2015
Core healthcare issue/need being addressed
Birth asphyxia induced neonatal mortality and morbidity
Key value add
Impact of the solution
Regulatory/Quality Certifications
CE certified; ISO 13485
DownloadDetailed description of the solution and its components
MiraCradle®- Neonate Cooler uses the advanced savE® phase change material technology.
Phase Change Materials (PCMs) are special thermal energy storage materials that store and release heat at a particular temperature. The thermal energy transfer occurs when the material changes phasefrom solid to liquid or liquid to solid.
MiraCradle®- Neonate Cooler uses the first of its kind – Form Stable PCMs. PCMs have been incorporated in a polymer matrix to ensure that when changing phase from solid to liquid PCMs retain its shape and form avoiding any risk of the PCM leaking from its encapsulation, thus making it completely safe for the user as well as the patient.
To ensure precise temperature control, MiraCradle®- Neonate Cooler uses a cascaded system of PCMs. Cascaded system is a patented technology that employs use of two or more form stabilized PCM mattresses with melt/freeze at different temperatures. By engineering the melting points, thicknesses, conductivities and placement of the involved layers, a “quasi-automated” cooling system is created, which, while being completely non-electric, behaves like an electric servo-automated cooling device
Awards and recognition
Geographical presence
Scientific evidence
Four clinical studies have been published in India to show that the temperature stays stable for 72 hours.
About the Organization
Name of the organization
Pluss Advanced Technologies Pvt. Ltd.
Office Addres
B-205 Pioneer Urban Square, Sector 62, Gurgaon- 122008
Udit Mangal, VP- Business Development
MedGames - Simulated learning platform Year of launch: 2019
Core healthcare issue/need being addressed
Key value add
Impact of the solution
Video links
Game Video Link
https://www.youtube.com/watch?v=Csi4QF2u_YA
Impact Video Link
https://www.youtube.com/watch?v=JD46m3BpwZ4&feature=youtu.be
Detailed description of the solution and its components
The game based platform has been used to develop a serious game app for “Alliance for Saving Mothers and Newborns” (ASMAN), which is an initiative to improve the survival of mothers and newborns by providing better quality of care, during the crucial 48 to 60-hour period around childbirth, using technology innovations, in public health centers.
The ASMAN game assists the nurses and skilled birth-attendants in early identification of complications during pregnancy and child-birth and practice their evidence-based management. The app simulates 30 cases of complicated labor in the areas of post-partum hemorrhage, prolonged & obstructed labor, severe eclampsia/pre-eclampsia, pre-term labor, gestational diabetes, malaria & HIV in pregnancy, maternal & child sepsis, and hypothermia to name a few.
A leader board helps nurses track their progress and engage in healthy competition with their peers. The web dashboard enables program officers to monitor progress remotely and ensure compliance. The data on the levels cleared by each player can be used to personalize their learning paths and provide insights on their clinical skills. All the usage data captured in the app helps generate actionable insights on the clinical skills that need improvement thus providing strategic inputs on further areas of intervention to reduce maternal and new born deaths.
The platform is easily customizable and can be extended simulate cases for other areas such as infection control, medication administration, assessment skills, care prioritization, wound/dressing, ECG interpretation and so on. The game facilitates anytime, anywhere learning and is available on mobile devices.
Awards and recognition
MIT Solve Finalist 2018 – The game app was selected as a Finalist among 1,150 applicants from 110 countries at the Massachusetts Institute of Technology’s Solve Challenge in the category : Frontlines of Health
Other resources
ASMAN alliance website link for updated game information
https://www.asmanalliance.in/gamification-2/
Testimonials from healthcare providers (@ASMANalliance twitter feed)
ASMAN is giving #nurses the confidence to handle even high-risk and complicated cases. The result – we are saving more lives of #mothers and #newborns: Dr. Piyush at #PHC Raoti in #Ratlam, Madhya Pradesh
https://twitter.com/ASMANalliance/status/1173600560475340807
To help nurses sharpen their decision-making skills, #ASMAN app features 29 case-based interactive games, developed by our partner #Bodhi. Nurses must beat the clock and save a life in the game.
https://twitter.com/ASMANalliance/status/1164151959827300353
A little healthy competition is a good thing! As our nurses play #ASMAN games, they learn important aspects about obstetric and neonatal care. Moreover, the leader board helps them to monitor their progress as compared to their peers
https://twitter.com/ASMANalliance/status/1188739843758542848
Geographical presence
About the Organization
Name of the organization
Bodhi Health Education
Office Addres
1 Fusionopolis Way #03-06 Singapore 138632 Sector-47, ILD Trade Centre, Sohna Road, Gurugram,Haryana 122018, India
Shrutika Girdhar. CTO & Co-founder
Doxper Year of launch: 2016
Core healthcare issue/need being addressed
Updating electronic health records (EHRs) is often the responsibility of doctors and care providers, but very few like the burden and inconvenience of typing. This is especially true in countries where the doctor-patient ratio is poor and the average consultation time is a handful of minutes. Patients in 18 countries representing about 50% of the global population spend 5 minutes or less with their primary care physician as per a 2017 British Medical Journal survey.
EHR systems globally are also the source of real world and longitudinal patient data. However,
providers in 135 countries are still using pen and paper and are looking for a cost‐effective digitisation solution that does not force behaviour change.
Key value add
Impact of the solution
Regulatory/Quality Certifications
Video links
Doxper featured at MIT Solve, United Nations
https://www.youtube.com/watch?v=KqsatdJLiCM&t=1s
Press coverage
3rd Apr 2020: How an AI-powered pen helps health workers to digitise patient records
https://indiaai.in/article/how-an-ai-powered-pen-helps-health-workers-to-digitise-patient-records
19th Feb 2020: How this startup is using pen and paper to transform India’s healthcare industry
https://economictimes.indiatimes.com/small-biz/startups/features/how-this-startup-is-using-pen-and-paper-to-transform-indias- healthcare-industry-doxper/articleshow/74202343.cms
18th Sep 2019: Indian Healthcare’s Digital Wonder, How an Indian healthcare company digitised five million health records in four years.
https://www.healthcareexecutive.in/blog/digital-wonder?rq=doxper
14th Aug 2019: Health-tech startup Doxper raises $4 million as part of Series A
https://www.livemint.com/companies/start-ups/health-tech-startup-doxper-raises-4-million-as-part-of-series-a-1565752054396.html
23rd Apr 2018: On A Mission To Digitise Global OPD Processes, Healthtech Startup Doxper Raises $1.1 Mn Funding
https://inc42.com/buzz/on-mission-to-digitise-global-opd-processes-healthtech-iot-startup-doxper-raises-1-1-mn-funding/
Detailed description of the solution and its components
Doxper is an AI assisted digital pen and encoded paper solution.
Core workflow
Patient engagement features include automated follow-up compliance, content sharing, SMS campaigns.
Doctors also regularly receive Excel files of their structured patient data, so that they can engage in research.
In hospitals, we connect the OPD to various service departments in real-time so that tests, medicines, admission, surgery advised etc by the doctor can be picked up before the patient walks out of the hospital. Patients proactively receive a phone call, addressing queries like appointment booking, cost of services, the need to fast etc, thereby improving overall patient experience.
Awards and recognition
Geographical presence
About the Organization
Name of the organization
InformDS Technologies Private Limited
Office Addres
6088, C Wing, Oberoi Garden Estates, Chandivali Farm Road, Andheri East, Mumbai 400072
Parag Agarwal, Head Partnerships & International